17 April 2024
Elston Quarterly Portfolio Update Q2 2024
In this video, Portfolio Manager David Seager provides his perspective on the key questions discussed in the recent quarterly asset allocation meeting. Read more
23rd February 2021 - Asset Management
This article was originally published on LivewireMarkets.com on February 23rd, 2021
February is one of the most anticipated months of the year. Not because of Valentines Day, Chinese New Year or even the hot weather. No, February is the month to watch for Australian investors as reporting season kicks off.
We’re well into the thick of earnings season for the month and after a year of lockdowns, deferred dividends and a significant lack of earnings growth, the February 2021 reporting season was one of the most anticipated.
To say it has got off to a flier would be an understatement. Investors have breathed a sigh of relief as:
In this video, large-cap manager and CEO at Elston Group, Andrew McKie unpacks the beginning of the February reporting season – detailing the biggest surprise and the ASX warrior who disappointed the market. McKie also provides his thesis behind the ASX stock he is most closely watching into reporting season, analysing why post-COVID tailwinds should allow for its healthy recovery.
What company surprised you most this reporting season
A positive surprise for us was James Hardie. We’ve owned James Hardie for a few years now, and although we knew that there would be some recovery to housing starts in the U.S., which is really the shining light division for Hardie’s, it’s come in obviously a lot stronger. So the property market in the U.S. is very strong. Similar drivers to what we’re starting to see here in Green Shoots in Australia, as well. Housing starts are the highest since 2006 in the U.S. now, so that was a very good result in terms of sales growth, but also margin expansion. If we look at the opportunities that we have in large caps, two years ago, Hardie’s in February ’19 was somewhere around $17 a share. And the market was looking at the business as a cyclical building materials business, whereas we saw it as a structural growth story.
As fibre cement takes market share in the U.S, as they penetrate that market, they had the ability to grow sales, independent of what was happening with housing starts. And then from an efficiency point of view, we saw some improvement there in their margins as well, as they convert those sales to higher EBIT margins as well. So, now we’ve been lucky enough that there has been also that recovery in volumes, but it’s doing the work on the core drivers of revenue and expenses to identify where the market is underestimating the growth potential of that business site. And that’s a classic case of that two years ago versus where we are now.
What company disappointed you this reporting season?
In terms of what we own, Origin has pre-announced their earnings at the time, as we speak. It’s energy markets, so wholesale electricity prices are really below their costs of production. So, that’s been a challenging division for them in the short term and where we see that long term. But there’s a slight miss there, and that’s probably an area of disappointment, but at this point, we’re actually reasonably happy. We’ve had some very good results from Hardie’s, I mentioned. From Macquarie, from Virgin Money, from Amcor. Some core sort of positions for us. So fingers crossed, it’s going reasonably well for us.
What company are you most looking forward to hearing from this reporting season?
It’s a little bit boring, but Ramsay Health Care. So with health care, you’re really looking at that defensive earnings profile and Ramsay being a private health provider does have a history of very good long-term growth in revenues. They’ve got that demographic support in terms of population growth, as well as an ageing population. But they have been impacted by COVID, which has really provided an opportunity for us to buy Ramsay at what we think is a discount to its long-term intrinsic value, due to that short-term COVID disruption.
They’ve had, in some instances, a lot of their hospitals have been shut, or they’ve been helping governments with dealing with COVID, particularly the UK and France. And so elective surgeries, they haven’t had that come through. They’ve had elevated costs.
So, the short-term uncertainty for us is providing that longer-term opportunity to buy a quality business. So we’ll be interested to see, particularly for domestic Australia, as we’ve done a little bit better from a containment point of view, how strongly are elective surgeries coming back? Because there will be a huge catch-up in demand there, we think, for elective surgeries as well. So that’s one to watch, we think for us to see if that thematic is right and that Ramsay is well-positioned for that recovery.
If you would like more information please call 1300 ELSTON or contact us to speak to one of our advisers.
17 April 2024
In this video, Portfolio Manager David Seager provides his perspective on the key questions discussed in the recent quarterly asset allocation meeting. Read more
10 April 2024
Elston Portfolio Manager Gary Merkel has picked three constituents of the ASX Small Ordinaries Index in the latest Livewire article. Read more
25 March 2024
Just before Easter, Livewire asked four fundies to pick which businesses they thought had the hop on some of the others in their investment universe. Read more
18 March 2024
Following on from the reporting season, Co-Founder and Portfolio Manager Bruce Williams has provided a brief overview of the recent results and what that indicates for the portfolio positioning. Read more
31 January 2024
The Australian Financial Review has recently named Elston Australian Emerging Leaders in their top performers 2023. Read the article to find out more. Read more
18 January 2024
In this video, Portfolio Manager Leon de Wet provides his perspective on the key questions discussed in the recent quarterly asset allocation meeting. Read more
1 December 2023
HUB24 announced the launch of a new whitepaper, ‘Directing the matrix: meeting the advice needs of high net worth clients’. Read now to get insights from Elston Head of Philanthropic Services Susan Chenoweth and many other experienced advisers. Read more
8 November 2023
Investing in what you are passionate about, or even what you consume everyday, can give you an edge. Find out what local stock Elston Co-Founder Bruce Williams has in mind. Read more
13 October 2023
What should advisers think about as they move to managed portfolios? Elston Head of Adviser Services Mark Smith shared his views on how to successfully make the transition. Read more
4 October 2023
We all know Australia is the lucky country, but could it soon be the luckiest? Elston Co-founder Andrew McKie believes it may be possible, and advisers need to take heed. Read more
21 September 2023
Andrew McKie joined 5 other industry leaders at LiveWire Live 2023 as they presented their shocking prediction for the future. What did he predict? And is it good news or bad news? Read more
14 September 2023
Portfolio Manager Leon de Wet has provided a brief overview of the recent reporting season results and what that indicates for future earnings and the portfolio positioning. Read more
25 August 2023
Are our two big supermarkets worth checking out? Read the latest Livewire Markets article to see what Elston Co-Founder and Portfolio Manager Bruce Williams thinks. Read more
12 August 2023
Should investors buy AMP or bypass it? See what Elston co-founder and portfolio manager Andrew McKie thinks and find out how he’s feeling about the ASX100 in general. Read more
1 August 2023
In this video, Portfolio Manager Leon de Wet provides his perspective on the key questions discussed in the recent quarterly asset allocation meeting. Read more
31 July 2023
What makes Carsales such an attractive stock? Elston Portfolio Manager Bruce Williams examines the key drivers that are working for this digital marketplace both here and overseas. Read more
26 July 2023
Last year, some bond indices fell into a black hole. Are good returns from fixed income investing still a galaxy far, far away? Or are there brighter days on the horizon? Read more
23 July 2023
In the latest Livewire's edition of Buy Hold Sell, Andrew McKie talked about which ASX-listed stocks he would want to own (or not own) in a Goldilocks scenario. Read more
20 July 2023
Elston Co-Founder Andrew McKie sat down with Han Lee from Livewire and Rob Crookston from WILSONS to discuss how they find “quality” companies on the ASX. Read more
15 July 2023
Andrew McKie was asked to analyse three stocks that are widely perceived to have those rock-solid qualities and assess whether they have become overcrowded, and name one quality company in the recent Livewire interview. Read more
12 July 2023
If you had a spare $10,000, how would you invest it? It's an interesting hypothetical and one that Elston Portfolio Manager Leon De Wet was happy to answer for Livewrire. Read the article to see his picks. Read more
7 July 2023
Inflation has proven to be more stubborn than expected. And so, the Reserve Bank has had no choice but to keep increasing interest rates. What could this mean for company earnings and how might that flow through to portfolios? Read more